An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

MedAlert Tag: Diabetes

FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

November 17, 2022

The FDA approved Tzield® (teplizumab-mzwv) injection, a new drug that can delay the onset of type 1 diabetes by several months or years. Type 1 diabetes occurs when the immune system attacks and destroys the cells that make insulin, requiring individuals to check their blood sugar regularly and deliver insulin shots to survive. Tzield deactivates the immune cells that attack insulin-producing cells, while increasing the proportion of cells that help moderate the immune system. Tzield must be delivered intravenously once daily for 14 consecutive days.

Read More